Taken together, PTHrP enhances CCL2 expression in osteoblasts, signifying the role of prostate cancer cell-derived PTHrP in bone metastasis, likely via enhanced CCL2 expression (6, 79, 80). The gene discussed is CCL2; the disease is Familial prostate cancer.